Healthcare & Longevity Development
A new category of medical real estate — between the high-technology clinic and the international longevity resort.
- Sector
- Healthcare & Hospitality
- Country
- Southern Europe
- Year
- 2024
- Status
- Active
Catalyst roleSponsor · Co-Investor · Capital Architect · Development Partner
Presented without company name or transaction figures. Amounts, investor names and commercial details are confidential under NDA.
The opportunity
Between the traditional hospital and the luxury resort, a new category of asset is emerging — combining preventive diagnostics, longevity medicine, rehabilitation, five-star hospitality, residences, research and wellness infrastructure.
Investment thesis
A physical asset that carries clinical demand, real-estate value and hospitality income at once is structurally more resilient than any of those businesses alone.
The asset
An integrated longevity and medical-hospitality development, designed so that diagnostics, care, hospitality and residences reinforce one another.
Catalyst role
Catalyst acted as sponsor, co-investor, capital architect and development partner — assembling the capital structure and coordinating an international consortium around the project.
International consortium
Private capital, family offices, strategic partners and debt were combined into a single structure fitted to the asset. Investor names and amounts are confidential.
Development strategy & long-term vision
Build an asset designed for decades — where medicine, hospitality and real estate compound into a durable, long-term ownership position.
Investment architecture
One project. Multiple layers of capital.
The capital structure was assembled to fit the asset — combining the layers below.
Milestones
- 01SponsorshipCatalyst assumes sponsor and capital-architect role.
- 02Capital formationCapital assembled across the consortium.
- 03DevelopmentDesign and development strategy defined.
- 04Long-term ownershipStructured for durable, long-term ownership.
Gallery



Representative imagery. Confidential material — valuation, shareholder information, exact IRR, commercial contracts and investor names — is not published without permission.
Building something that belongs here?
Submit a company or an infrastructure project for review.

